To date, no longitudinal human studies have directly assessed P2X7 expression or activity across the different stages of Chagas disease, nor clarified the influence of P2RX7 genetic polymorphisms on disease susceptibility or therapeutic response. This evidence concerns the gene P2RX7 and Chagas disease.